Lantern Pharma Inc
Lantern Pharma Inc (LTRN) Options Open Interest
LTRN options open interest is 2,331 contracts. The 2-week average daily volume is 224 contracts across the chain.
Read more
Monitoring LTRN open interest helps you see where real money is positioned on Lantern Pharma Inc's options and which strikes are attracting the most commitment from traders. Lantern Pharma Inc's open interest reflects the total number of outstanding contracts that have not been closed or exercised, making it a powerful gauge of liquidity, conviction, and potential support and resistance zones. Use our scanner to monitor LTRN options open interest in real time and find the strikes that matter.
Open interest is distinct from volume: volume counts how many contracts are traded in a session, while open interest counts how many remain open at the end of the day. Rising LTRN options open interest alongside rising volume suggests new positions are being built, while falling open interest signals positions are being closed. Heavy open interest at specific strikes often acts as a magnet near expiration and can hint at where dealers and large traders expect Lantern Pharma Inc to settle.
Lantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development process. Its advanced drug candidate is LP-100, which is in phase II clinical trials to treat metastatic, castration-resistant, and prostate cancer. The company also develops LP-300 as a combination therapy for non or never-smokers with non-small cell lung cancer adenocarcinoma. In addition, its preclinical development drug candidate is LP-184, an alkylating agent that damages DNA in cancer cells that overexpress certain biomarkers or that harbor mutations in DNA repair pathways.
Further, the company operates ADC program, an antibody drug conjugate therapeutic approach for cancer treatment. Additionally, the company's artificial intelligence platform RADR uses big data analytics and machine learning for combining molecular data. The company was incorporated in 2013 and is headquartered in Dallas, Texas.
Pin risk into expiration, dealer positioning, liquidity checks for large orders — all of it starts with knowing where LTRN open interest is concentrated. Our scanner maps Lantern Pharma Inc's open interest across every strike and expiry, flags unusual buildups, and lets you drill into the contracts that institutional money is actually holding. Trade Lantern Pharma Inc's options open interest as the signal it is, not as an afterthought.
| 6.00 | — | 0.05 | 0.05 | 522% | +0.1351 | 121 |
| 2.00 | — | 0.05 | 0.05 | 284% | +0.1948 | 67 |
| 5.00 | — | 0.05 | 0.05 | 487% | +0.1406 | 49 |
| 3.00 | — | 2.80 | 2.80 | 1,000% | +0.6961 | 17 |
| 1.00 | — | 0.95 | 0.95 | 1,000% | +0.8515 | 11 |
| 3.00 | 0.15 | 3.80 | 1.98 | 51% | -1.0000 | 27 |
| 2.00 | — | 2.75 | 2.75 | 1,000% | -0.2393 | 25 |
| 4.00 | 1.10 | 4.80 | 2.95 | 85% | -1.0000 | 2 |
| 1.00 | — | 1.90 | 1.90 | 1,000% | -0.1485 | 1 |
| 6.00 | 3.00 | 6.80 | 4.90 | 88% | -1.0000 | 1 |
As of September 30, 2026
Follow the money
Track LTRN open interest across every strike and expiration, identify where conviction is building, and trade with the positioning data on your side.
Start your 14-day free trial→